- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01357343
Integrated Chiropractic and Acupuncture Treatment for Low Back Pain
Effect of an Integrative Approach of Chiropractic and Traditional Chinese Medicine Care on Low Back Pain: A Randomized Controlled Trial
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This study is being conducted at the Southern California University of Health Sciences. Eligible subjects will be randomized to one of three treatment groups: chiropractic care alone, acupuncture care alone, and chiropractic and acupuncture care combined.
Subjects will be treated on pragmatic basis for 60 days and then followed up for an additional 60 days. All examinations and treatments will be provided free of charge. The expected benefits for the participants are decreased pain and improved function.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Fase 2
Kontakter og lokationer
Studiesteder
-
-
California
-
Whittier, California, Forenede Stater, 90604
- Southern California University of Health Sciences
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Are 18 years or older
- Have a current episode of low back pain
Exclusion Criteria:
- Received chiropractic treatment or other manipulative therapies within the last month
- Received acupuncture treatment within the last month
- Visceral, systemic or joint inflammatory disease with referred pain to the back or pelvis
- Non-mechanical low back pain
- A history of low back surgery
- Osteoporosis
- Spondylolisthesis
- Coagulation disorder or are taking anticoagulant medication
- Prolonged systemic corticosteroid medication
- Progressive unilateral lower limb muscle weakness
- Symptoms or signs of cauda equina syndrome (e.g., bowel or bladder dysfunction)
- Severe concurrent illness (e.g., cancer, heart diseases, psychiatric disorders)
- Known pregnancy
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Acupuncture
Acupuncture needling, moxa, Tui Na and cupping
|
Acupuncture needling, moxa, Tui Na and cupping.
|
|
Aktiv komparator: Chiropractic care
Chiropractic adjustments and active and passive physical modalities.
|
Spinal manipulation and active and passive therapy.
|
|
Aktiv komparator: Integrated Chiropractic and Acupuncture
|
Acupuncture needling, moxa, Tui Na and cupping.
Spinal manipulation and active and passive therapy.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Pain numeric rating scale.
Tidsramme: Change from baseline to 60 days
|
This outcome will measure changes in the participant's level of low back pain.
|
Change from baseline to 60 days
|
|
Disability due to low back pain
Tidsramme: Change from baseline to 60 days
|
We will be using Roland-Morris scale to measure disability due to low back pain.
|
Change from baseline to 60 days
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Quality of life
Tidsramme: Change from baseline to 60 days days
|
Quality of life is often reduced due to low back pain.
The SF-36 outcome measure will be used to determine if the treatment has any effect on quality of life of the participants.
|
Change from baseline to 60 days days
|
|
Patient satisfaction with treatment
Tidsramme: Change from baseline to 60 days
|
We will be using Cherkin-satisfaction scale to measure patient's satisfaction with the treatment offered.
|
Change from baseline to 60 days
|
|
Self generated survey of outcomes
Tidsramme: Change from baseline to 60 days days
|
Frequency of symptoms, Medication use, Lost work time, Health services utilization
|
Change from baseline to 60 days days
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Anupama Kizhakkeveettil, MAOM, Southern California University of Health Sciences
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- KIZH003
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Lændesmerter
-
Bozok UniversityAfsluttet
-
Health Services Academy, Islamabad, PakistanUkendtmHealth | Genoptagelse | Teach-back kommunikationPakistan
-
Rush University Medical CenterAfsluttetPatientuddannelse | Teach-back kommunikation | Efter besøgsinstruktioner | PatientforståelseForenede Stater
-
InQpharm GroupAfsluttetBlodtryk | Low Density Lipoprotein KolesterolniveauTyskland
-
Tyra Biosciences, IncRekrutteringLow Grade Upper Tract Urothelial CarcinomaForenede Stater
-
Otsuka Pharmaceutical Co., Ltd.AfsluttetHyper-low-density Lipoprotein (LDL) KolesterolæmiJapan
-
National Taiwan University HospitalBuddhist Tzu Chi General Hospital; Taipei Medical University Hospital; E-DA... og andre samarbejdspartnereUkendtKoloskopi | Udrensning af tyktarm | Low-Reside diætTaiwan
-
Medical College of WisconsinChildren's WisconsinAktiv, ikke rekrutterendeSimulering af fysisk sygdom | Trakeostomi komplikation | Teach-back kommunikationForenede Stater
-
Marmara UniversityAfsluttetTeach-back kommunikationTyrkiet (Türkiye)
-
Otsuka Pharmaceutical Co., Ltd.AfsluttetHyper-low-density Lipoprotein (LDL) KolesterolæmiJapan